Peregrine Semiconductor Corporation
CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands) (unaudited) |
|||||||
September 28, | December 29, | ||||||
2013 | 2012 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 17,206 | $ | 44,106 | |||
Short-term marketable securities | 23,213 | 30,361 | |||||
Accounts receivable, net | 18,322 | 13,353 | |||||
Inventories | 52,311 | 57,017 | |||||
Prepaids and other current assets | 7,955 | 11,108 | |||||
Total current assets | 119,007 | 155,945 | |||||
Property and equipment, net | 23,358 | 22,871 | |||||
Long-term marketable securities | 22,664 | 18,892 | |||||
Other assets | 211 | 210 | |||||
Total assets | $ | 165,240 | $ | 197,918 | |||
Liabilities and stockholders’ equity | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 12,465 | $ | 22,306 | |||
Accrued liabilities | 9,151 | 12,672 | |||||
Accrued compensation | 3,664 | 5,726 | |||||
Customer deposits | 4,954 | 24,425 | |||||
Deferred revenue | 5,627 | 12,755 | |||||
Current portion of obligations under capital leases | 10 | 11 | |||||
Total current liabilities | 35,871 | 77,895 | |||||
Obligations under capital leases, less current portion | 18 | 18 | |||||
Other long-term liabilities | 826 | 886 | |||||
Stockholders’ equity: | |||||||
Common stock | 33 | 32 | |||||
Additional paid-in capital | 346,837 | 340,221 | |||||
Accumulated deficit | (218,158 | ) | (220,935 | ) | |||
Accumulated other comprehensive loss | (187 | ) | (199 | ) | |||
Total stockholders’ equity | 128,525 | 119,119 | |||||
Total liabilities and stockholders’ equity | $ | 165,240 | $ | 197,918 | |||
Peregrine Semiconductor Corporation
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands) (unaudited) |
||||||||
Nine Months Ended | ||||||||
September 28, | September 29, | |||||||
2013 | 2012 | |||||||
Operating activities | ||||||||
Net income | $ | 2,777 | $ | 1,645 | ||||
Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
Depreciation and amortization | 4,825 | 3,132 | ||||||
Stock-based compensation | 4,854 | 3,116 | ||||||
Revaluation of warrants to fair value | — | 633 | ||||||
Imputed interest related to deposit arrangements, net | (307 | ) | 273 | |||||
Amortization of premium and discount on investments, net | 293 | 48 | ||||||
Cash received for lease incentives | 135 | — | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | (4,956 | ) | (8,727 | ) | ||||
Inventories | 4,717 | (26,709 | ) | |||||
Prepaids and other current and noncurrent assets | 3,676 | (6,354 | ) | |||||
Accounts payable and accrued liabilities | (16,144 | ) | 21,606 | |||||
Customer deposits | (11,425 | ) | 29,791 | |||||
Deferred revenue | (6,787 | ) | 7,122 | |||||
Net cash provided by (used in) operating activities | (18,342 | ) | 25,576 | |||||
Investing activities | ||||||||
Purchases of property and equipment | (5,304 | ) | (13,157 | ) | ||||
Purchase of marketable securities | (28,552 | ) | (48,462 | ) | ||||
Sale of marketable securities | 31,607 | — | ||||||
Net cash used in investing activities | (2,249 | ) | (61,619 | ) | ||||
Financing activities | ||||||||
Proceeds from customer deposit financing arrangement | — | 13,000 | ||||||
Payments on customer deposit financing arrangement | (8,046 | ) | — | |||||
Proceeds from line of credit | — | 3,000 | ||||||
Payments on line of credit | — | (10,749 | ) | |||||
Payments on obligations under capital leases | (7 | ) | (661 | ) | ||||
Payments on notes payable | — | (1,618 | ) | |||||
Proceeds from exercise of stock options | 1,759 | 369 | ||||||
Proceeds from exercise of warrants | — | 31 | ||||||
Proceeds from initial public offering, net of offering cost | — | 80,278 | ||||||
Costs paid in connection with initial public offering | — | (1,707 | ) | |||||
Net cash provided by (used in) financing activities | (6,294 | ) | 81,943 | |||||
Effect of exchange rate changes on cash and cash equivalents | (15 | ) | (12 | ) | ||||
Net change in cash and cash equivalents | (26,900 | ) | 45,888 | |||||
Cash and cash equivalents at beginning of period | 44,106 | 12,119 | ||||||
Cash and cash equivalents at end of period | $ | 17,206 | $ | 58,007 | ||||
Peregrine Semiconductor Corporation
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (in thousands, except per share data) (unaudited) |
||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||
September 28,
2013 |
September 29,
2012 |
September 28,
2013 |
September 29,
2012 |
|||||||||||||||||||||||||||
Gross profit - GAAP | $ | 25,253 | 42.1 | % | $ | 25,015 | 41.3 | % | $ | 65,789 | 41.4 | % | $ | 52,491 | 37.3 | % | ||||||||||||||
Non-cash compensation expense (1) | 238 | 0.4 | 133 | 0.2 | 652 | 0.4 | 404 | 0.2 | ||||||||||||||||||||||
Gross profit - Non-GAAP | $ | 25,491 | 42.5 | % | $ | 25,148 | 41.5 | % | $ | 66,441 | 41.8 | % | $ | 52,895 | 37.5 | % | ||||||||||||||
Income from operations - GAAP | $ | 4,266 | 7.1 | % | $ | 4,670 | 7.7 | % | $ | 2,885 | 1.8 | % | $ | 2,790 | 2.0 | % | ||||||||||||||
Non-cash compensation expense (1) | 1,728 | 2.9 | 1,152 | 1.9 | 4,854 | 3.1 | 3,116 | 2.2 | ||||||||||||||||||||||
Income from operations - Non-GAAP | $ | 5,994 | 10.0 | % | $ | 5,822 | 9.6 | % | $ | 7,739 | 4.9 | % | $ | 5,906 | 4.2 | % | ||||||||||||||
Net income - GAAP | $ | 4,433 | 7.4 | % | $ | 4,713 | 7.8 | % | $ | 2,777 | 1.7 | % | $ | 1,645 | 1.2 | % | ||||||||||||||
Non-cash compensation expense (1) | 1,728 | 2.9 | 1,152 | 1.9 | 4,854 | 3.1 | 3,116 | 2.2 | ||||||||||||||||||||||
Net income - Non-GAAP | $ | 6,161 | 10.3 | % | $ | 5,865 | 9.7 | % | $ | 7,631 | 4.8 | % | $ | 4,761 | 3.4 | % | ||||||||||||||
Diluted net income per share attributable to common stockholders - GAAP | $ | 0.12 | $ | 0.10 | $ | 0.08 | $ | 0.02 | ||||||||||||||||||||||
Adjustment to reflect conversion of preferred stock at the beginning of period | — | 0.04 | — | 0.03 | ||||||||||||||||||||||||||
Non-cash compensation expense | 0.05 | 0.03 | 0.13 | 0.10 | ||||||||||||||||||||||||||
Diluted net income per share - Non-GAAP | $ | 0.17 | $ | 0.17 | $ | 0.21 | $ | 0.15 | ||||||||||||||||||||||
Net income attributable to common stockholders - GAAP | $ | 4,433 | $ | 2,434 | $ | 2,777 | $ | 283 | ||||||||||||||||||||||
Net income - Non-GAAP | $ | 6,161 | $ | 5,865 | $ | 7,631 | $ | 4,761 | ||||||||||||||||||||||
Shares used to compute diluted net income per share attributable to common stockholders - GAAP | 35,804 | 24,351 | 35,738 | 12,692 | ||||||||||||||||||||||||||
Adjustment to reflect conversion of preferred stock at the beginning of period | — | 9,347 | — | 18,039 | ||||||||||||||||||||||||||
Shares used to compute diluted net income per share - Non-GAAP | 35,804 | 33,698 | 35,738 | 30,731 | ||||||||||||||||||||||||||
(1) Includes stock-based compensation as follows: | ||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||
September 28,
2013 |
September 29,
2012 |
September 28,
2013 |
September 29,
2012 |
|||||||||||||||||||||||||||
Cost of net revenue | $ | 238 | $ | 133 | $ | 652 | $ | 404 | ||||||||||||||||||||||
Research and development | 537 | 368 | 1,534 | 935 | ||||||||||||||||||||||||||
Selling, general and administrative | 953 | 651 | 2,668 | 1,777 | ||||||||||||||||||||||||||
Total | $ | 1,728 | $ | 1,152 | $ | 4,854 | $ | 3,116 |